Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nod

by Kathy Jones on  May 25, 2012 at 6:12 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

Mumbai-based drug maker Sun Pharmaceuticals has revealed that its abbreviated new drug application for Azelastine HCL nasal spray has been approved by the US Food and Drug Administration for manufacturing in the strength of 0.1 per cent (137 mcg/spray).
 Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nod
Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nod

The company said that Azelastine HCL is the generic version of Medpointe Pharm HLC's Astelin nasal spray and is used in treating symptoms of seasonal allergic rhinitis such as rhinorrhea, sneezing and nasal pruritus.

It added that the nasal spray has annual sales of $144 million in the United States and can also be used to treat rhinorrhea, nasal congestion and postnasal drip in adults.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Allergic Rhinitis Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive